How plant-derived natural compounds behave in the human body
Computational Exploration of Plant Natural Products Bioactivity and Bioavailability in Human Health
['FUNDING_OTHER'] · MICHIGAN STATE UNIVERSITY · NIH-11323127
Researchers use computer models to see how plant-based natural compounds move through and act in the human body, which could help people with cancer and other health problems.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MICHIGAN STATE UNIVERSITY (nih funded) |
| Locations | 1 site (EAST LANSING, UNITED STATES) |
| Trial ID | NIH-11323127 on ClinicalTrials.gov |
What this research studies
This project uses computer simulations at the molecular (nanoscale) level to model how natural compounds from plants, fungi, or bacteria bind to proteins and cross cell membranes. The team runs detailed molecular dynamics and binding calculations focused on compounds where they already have collaborations and data. Examples include looking at how lignin interacts with human hormone receptors, how sorgoleone might affect mitochondria, and membrane permeability for cancer drugs like vinblastine. The computational results are intended to guide laboratory experiments and inform safer or more effective use of natural-product-based therapies.
Who could benefit from this research
Good fit: People with cancer or others interested in natural-product-based therapies or future clinical studies informed by this work would be the most relevant patient group.
Not a fit: Patients seeking immediate treatment changes or those with conditions unrelated to drug delivery or natural-product therapies are unlikely to see direct short-term benefit.
Why it matters
Potential benefit: If successful, this work could help improve how natural-product drugs reach their targets and identify new ways to use plant compounds for cancer and other conditions.
How similar studies have performed: Computational predictions have helped guide drug development before, but findings from simulations typically need laboratory and clinical follow-up before they translate into patient benefit.
Where this research is happening
EAST LANSING, UNITED STATES
- MICHIGAN STATE UNIVERSITY — EAST LANSING, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VERMAAS, JOSHUA V. — MICHIGAN STATE UNIVERSITY
- Study coordinator: VERMAAS, JOSHUA V.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Treatment, Cancers